马上注册,结交更多好友,享用更多功能,让你轻松玩转社区。
您需要 登录 才可以下载或查看,没有账号?立即注册
x
本帖最后由 wlxkxgq 于 2014-7-21 10:45 编辑
肺癌常见靶向药对应靶点表 | 药名 | EGFR
| T790M
| HER2
| HER3
| HER4
| KRAS
| ALK
| cMET
| cKIT
| FGFR
| V-1
| V-2
| V-3
| PDGFR
| HGFR
| PI3K
| 易瑞沙 | 37
| ↓
|
| |
| ↓ |
| ↓ |
| |
| |
| | ↓
|
| 特罗凯 | 2
| ↓
|
| |
| ↓ |
| ↓ |
| |
| |
| | ↓
|
| 克里唑蒂尼 |
| |
| |
| | 10
| 4
|
| |
| |
| | ↑
|
| INC280 |
| |
| |
| |
| 0.13 |
| |
| |
| |
| | PF299804 | 6
| ↑
| ↑
|
| ↑ |
| |
| |
| |
| |
| |
| 拉帕替尼 | 10.2
|
| 9.8 |
| |
| |
| |
| |
| |
| |
| AEE788 | 2
|
| 6 |
| |
| |
| |
| | ↑
|
| |
| | 阿法替尼 | 8
| 10
| 24.9
|
| 26.6 |
| |
| |
| |
| |
| |
| HM781-36b | 3.2
| 1
| 5.3
|
| 23.5 |
| |
| |
| |
| |
| |
| BKM120 |
| |
| |
| |
| |
| |
| |
| |
| 52 | ARQ197 |
| |
| |
| |
| 0.355 |
| |
| |
| |
| | xl184 |
| |
| |
| |
| 1.3 | 4.6
|
| | 0.04
|
| |
| | AZD8931 | 4
|
| 3? | 4
|
| |
| |
| |
| |
| |
| | cp724714 |
| | 10
|
| |
| |
| |
| |
| |
| |
| ARRY-380 |
| | 8
|
| |
| |
| |
| |
| |
| |
| XL880 |
| |
| |
| |
| 0.4 |
| |
| |
| |
| | AP26113 |
| |
| |
| | 0.63
|
| |
| |
| |
| |
| WZ4002 | 2
| 8
|
| |
| |
| |
| |
| |
| |
| | 凡德他尼 | ↑
|
| |
| |
| |
| |
| | 50
| ↑
|
| |
| 阿西替尼 |
| |
| |
| |
| | 1.7
|
| 0.1 | 0.2
| 0.2
| 1.6
|
| | ADZ9291 | 12.92 | 11.44 | 493.8 | | | | | | | | | | | | | |
|
|
|
|
共34条精彩回复,最后回复于 2016-9-12 00:12
尚未签到
尚未签到
本帖最后由 wlxkxgq 于 2014-3-3 17:01 编辑
肺癌常见靶向药对应靶点表(续表) | 药名 | EGFR
| T790M
| HER2
| HER3
| HER4
| KRAS
| ALK
| cMET
| cKIT
| FGFR
| V-1
| V-2
| V-3
| PDGFR
| HGFR
| PI3K
| 阿帕替尼 | | | | | | | | | | | | 1 | | | | | 西地尼布 | | | | | | | | | ↑ | | <1 | <1 | <1 | ↑ | | | BIBF1120 | | | | | | | | | | 69 | 34 | 13 | 13 | 59 | | | TIVO-1 | | | | | | | | ↑ | ↑ | ↑ | 0.21 | 0.16 | 0.24 | ↑ | | | 索拉菲尼 | | | | | | ↑ | | | ↑ | | | 6 | 6 | 22 | | | 舒尼替尼 | | | | | | | | | | | 15 | 38 | 30 | 55 | | | 瓦他拉尼 | | | | | | | | | | | 60 | 37 | 600 | ↑ | | | 帕唑帕尼 | | | | | | | | | 140 | 74 | 10 | 30 | 47 | 84 | | | HKI-272 | 92 | | 59 | | | | | | | | | | | | | | 多维替尼 | | | | | | | | | 2 | 8 | 13 | 13 | 13 | | | |
|
|
|
|
尚未签到
我是新手,希望找到更多靶向药和它们的有效靶点,指导用药。 |
|
|
|
尚未签到
尚未签到
尚未签到
尚未签到
尚未签到
尚未签到